Jamaica’s new cannabis permits promise traditional ganja farmers a path into the legal market. Whether that path works remains to be seen.
Texas cannabis laws created a strange split market of hemp, medical cannabis, and marijuana prohibition. Here’s how the confusion took hold.
We legalized weed in most states. So why does it still feel broken? Ten voices on the cannabis frontline explain what got built, what got broken and what’s still worth saving.
From coffee-counter rumor to federal raids and adult-use legalization, one Montana insider looks at how the state built its cannabis market.
Georgia doctors urged Gov. Kemp to veto SB 220—but their claims don’t hold up under scrutiny.
Before he built one of Texas’ largest hemp companies, Lukas Gilkey was boarding drug boats in the Caribbean Sea. What he saw there convinced him the war on drugs was idiotic. What he built after may soon be banned by the same federal government he used to work for.
The TSA updated its public-facing Medical Marijuana page on April 27, the day before Schedule III rescheduling took effect, listing cannabis as permitted in carry-on and checked bags with “Special Instructions.” The agency hasn’t written those instructions. Here’s what the change means, who qualifies, and what hasn’t changed at the checkpoint.
Cannabis has gone from underground taboo to a $149 billion global industry in a decade. Here’s what changed between 2016 and 2026 — and what the Green Rush got wrong.
Cannabis is quietly reshaping global trade and diplomacy in 2026. From the U.S. rescheduling to Ukraine’s post-war reconstruction strategy, Costa Rica’s first major European export and Morocco’s legal pivot, the plant is emerging as a geopolitical tool in a world running out of conventional options.
Six years after predicting cannabis would trigger crime and psychosis epidemics, the data says otherwise. So why is the anti-weed media machine still profitable?
The renegade litigator who spent a decade suing federal drug agencies is now writing their policy from inside the building. What his trajectory tells us about how social movements actually succeed — and fail.
New data from YouGov shows a majority of Americans support marijuana legalization across party lines — and an overwhelming majority support medical use specifically. The poll was conducted just days before the Trump administration moved marijuana to Schedule III.
Jamaica’s new cannabis permits promise traditional ganja farmers a path into the legal market. Whether that path works remains to be seen.
Texas cannabis laws created a strange split market of hemp, medical cannabis, and marijuana prohibition. Here’s how the confusion took hold.
We legalized weed in most states. So why does it still feel broken? Ten voices on the cannabis frontline explain what got built, what got broken and what’s still worth saving.
From coffee-counter rumor to federal raids and adult-use legalization, one Montana insider looks at how the state built its cannabis market.
Georgia doctors urged Gov. Kemp to veto SB 220—but their claims don’t hold up under scrutiny.
Before he built one of Texas’ largest hemp companies, Lukas Gilkey was boarding drug boats in the Caribbean Sea. What he saw there convinced him the war on drugs was idiotic. What he built after may soon be banned by the same federal government he used to work for.
The TSA updated its public-facing Medical Marijuana page on April 27, the day before Schedule III rescheduling took effect, listing cannabis as permitted in carry-on and checked bags with “Special Instructions.” The agency hasn’t written those instructions. Here’s what the change means, who qualifies, and what hasn’t changed at the checkpoint.
Cannabis has gone from underground taboo to a $149 billion global industry in a decade. Here’s what changed between 2016 and 2026 — and what the Green Rush got wrong.
Cannabis is quietly reshaping global trade and diplomacy in 2026. From the U.S. rescheduling to Ukraine’s post-war reconstruction strategy, Costa Rica’s first major European export and Morocco’s legal pivot, the plant is emerging as a geopolitical tool in a world running out of conventional options.
Six years after predicting cannabis would trigger crime and psychosis epidemics, the data says otherwise. So why is the anti-weed media machine still profitable?
The renegade litigator who spent a decade suing federal drug agencies is now writing their policy from inside the building. What his trajectory tells us about how social movements actually succeed — and fail.
New data from YouGov shows a majority of Americans support marijuana legalization across party lines — and an overwhelming majority support medical use specifically. The poll was conducted just days before the Trump administration moved marijuana to Schedule III.
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!